Edition:
United States

People: Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

1.28USD
3:59pm EST
Change (% chg)

$0.01 (+1.18%)
Prev Close
$1.27
Open
$1.28
Day's High
$1.31
Day's Low
$1.27
Volume
16,879
Avg. Vol
67,470
52-wk High
$10.68
52-wk Low
$1.12

Rea, Janet 

Ms. Janet Rose Rea, M.S.P.H., is Vice President - Regulatory Affairs and Quality of Atossa Genetics, Inc. Ms. Rea has nearly 35 years of industry leadership experience in regulatory affairs and quality. A Washington native, she obtained her B.S. degree in Microbiology from the University of Washington and was conferred a Master's of Science of Public Health from the same institution. Her career in the healthcare industry started with Miami, FL-based Dade Division of then American Hospital Supply Corporation (now Baxter), followed by Genetic Systems, and she was an early employee of Seattle-based Immunex Corporation where she played a key role in the company's first licensed product, LEUKINE®. She held positions with increasing levels of responsibility with MDS Pharma, Targeted Genetics, and executive positions with AVI BioPharma (now Sarepta), Poniard Pharmaceuticals and Protein Sciences Corporation (Meriden, CT), and Therapeutic Proteins International (Chicago, IL). She has also operated a consulting practice of both small and large organizations, and she has lectured at both Shoreline Community College and the University of Washington - Biomedical Regulatory Affairs Certificate and Master Program, where she was also appointed as an Assistant Clinical Professor.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Steven Quay

864,538

Kyle Guse

746,215

Cindy Atha

--

Janet Rea

--

Shu-Chih Chen

386,737

Stephen Galli

--
As Of  30 Dec 2014